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Abstract
Immunosenescence, the deterioration of immune system capability with age, may play a key role in mediating age-related
declines in whole-organism performance, but the mechanisms that underpin immunosenescence are poorly understood.
Biomedical research on humans and laboratory models has documented age and disease related declines in the telomere
lengths of leukocytes (‘immune cells’), stimulating interest their having a potentially general role in the emergence of
immunosenescent phenotypes. However, it is unknown whether such observations generalise to the immune cell
populations of wild vertebrates living under ecologically realistic conditions. Here we examine longitudinal changes in the
mean telomere lengths of immune cells in wild European badgers (Meles meles). Our findings provide the first evidence of
within-individual age-related declines in immune cell telomere lengths in a wild vertebrate. That the rate of age-related
decline in telomere length appears to be steeper within individuals than at the overall population level raises the possibility
that individuals with short immune cell telomeres and/or higher rates of immune cell telomere attrition may be selectively
lost from this population. We also report evidence suggestive of associations between immune cell telomere length and
bovine tuberculosis infection status, with individuals detected at the most advanced stage of infection tending to have
shorter immune cell telomeres than disease positive individuals. While male European badgers are larger and show higher
rates of annual mortality than females, we found no evidence of a sex difference in either mean telomere length or the
average rate of within-individual telomere attrition with age. Our findings lend support to the view that age-related declines
in the telomere lengths of immune cells may provide one potentially general mechanism underpinning age-related declines
in immunocompetence in natural populations.
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Introduction
Immunosenescence is the gradual deterioration of immune
system capability with age, and may be a major factor influencing
age-related declines in whole-organism performance [1]. Howev-
er, the physiological mechanisms that underpin immunosenes-
cence are poorly understood. Biomedical studies have revealed
age-related declines in the average length of immune cell
telomeres (protective nucleoprotein complexes found at the ends
of eukaryotic chromosomes) in humans and laboratory models [2–
4], and indicate that immune cell telomere lengths can act as
biomarkers of age-related disease [5]. This research has led to the
suggestion that age-related declines in immune cell telomere
lengths may contribute to the immunosenescence-related health
declines previously documented in humans and wild vertebrates
[6]. Studies of wild birds have now frequently documented age-
related declines in the telomere lengths of nucleated erythrocytes
(red blood cells) [7,8 but see 4], which share the same
haematopoietic stem cell precursors as immune cells. However,
despite growing evidence of immunosenescence in wild vertebrate
populations [9], it has yet to be investigated whether such age-
related declines in telomere length also occur in the immune cell
populations of wild vertebrates.
Telomeres consist in part of repetitive sequences of DNA
(TTAGGG)n that often decrease in length over time (largely due to
oxidative damage and the end replication problem during cell
division; [10]) and may trigger cellular senescence once they
become critically short [6]. While the enzyme telomerase can
recover telomere length, telomerase expression appears to be
suppressed in the somatic cells of many mammals, due perhaps to
a role for telomere attrition in tumor suppression mechanisms
[11]. Age-related declines in the telomere lengths of immune cells
per se may be expected to arise as (i) many immune cells are
constantly renewed via the repeated division of stem cell
precursors and (ii) cells of the adaptive immune system (B- and
T-lymphocytes) undergo rapid proliferation in response to
invading pathogens [12]. As critically short telomeres can
compromise the function of haematopoietic stem cells (the cells
that produce immune cells and erythrocytes) [11] and reduce the
efficacy of immune cell responses (e.g. lymphocyte proliferation
potential) [13], age-related declines in immune cell telomere
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length may act to reduce immunocompetence in older individuals
[6].
An important factor influencing immune cell telomere length is
disease itself. Observational studies on humans have found shorter
immune cell telomere lengths in individuals suffering from age
related diseases such as cardiovascular disease and cancer [5]. A
comparison of the immune cell telomere lengths of laboratory
mice experimentally exposed to the infectious agent Salmonella
enterica compared to uninfected controls has shown that telomere
attrition can also occur as a direct consequence of infectious
disease [14]. Despite the clear link between current disease status
and immune cell telomere length, to date there have been no
assessments of their relationship within a wild vertebrate
population naturally infected with disease.
Here we use data from a longitudinal field study of wild
European badgers (Meles meles) to investigate whether the within-
individual age-related declines in immune cell telomere length
observed in humans and laboratory models extend to a wild
vertebrate population. European badgers are facultatively social
and polygynandrous mammals that occupy underground dens
(setts). Late life declines in reproductive success consistent with
senescence have already been observed in European badgers [15];
however the physiological mechanisms contributing to such
declines are currently unknown. As Mycobacterium bovis (the
causative agent of bovine tuberculosis, bTB), is known to be
present in our study population, we also investigate whether
shorter immune cell telomeres are associated with disease in the
wild.
Methods
Blood samples were collected from individually-marked badgers
of known-age (ranging from 0.3 to 10.3 years) routinely trapped as
part of a long-term study at Woodchester Park, Gloucestershire,
UK (see [16] for methods). DNA was successfully extracted from
361 buffy coat samples collected from 173 badgers captured and
sampled on 1–7 (median = 2) separate occasions between May
2012 and October 2013. Longitudinal measures (individuals
captured twice or more) were available for 88 individuals and
represented 76% of the total number of observations in the
dataset. Average immune cell relative telomere length was
determined via a robust and repeatable relative qPCR approach
then converted to an absolute telomere length measure (Kb) using
standard methods (see Information S1 for complete methodology).
The qPCR approach has been successfully utilised to estimate
telomere length in numerous ecological studies [7,17–19]. It is
particularly well suited to ecological field studies as it requires a
small DNA sample, and is cheap and high-throughput in
comparison to other methods available [20]. Furthermore, where
results from qPCR assays have been compared to other
methodologies (such as Terminal Restriction Fragment analysis)
they are generally found to be well correlated e.g. [21]. That said,
the qPCR technique cannot differentiate ‘true’ telomeric repeats
from interstitial telomere-like repeats located away from the
chromosome ends [22]. Whilst between-individual differences in
the incidence of interstitial repeats have the potential therefore to
add noise to comparisons of telomere length between groups of
individuals, they are unlikely to influence the results of longitudinal
studies (such as this one) where the within-individual change in
telomere length is of principal importance [18]. It should also be
noted that the absolute estimates of mean immune cell telomere
length and telomere attrition rates presented should currently be
treated with caution as they have not yet been verified with a
second independent methodology [20,23]. That said, their
inclusion here at least offers the potential for future comparisons
with other studies employing a similar methodology [24]. All work
was approved by the Food and Environment Research Agency
Ethical Review Committee and carried out under licence granted
by the Home Office under the 1986 Animal (Scientific Procedures)
Act.
Infection Status
Current bTB infection status was assessed at each capture event
using three diagnostic tests: i) the interferon-gamma (IFNc) test, an
enzyme immunoassay assessing lymphocyte responsiveness to an
M. bovis purified protein derivative, ii) the STAT-PAK (Chembio
Diagnostic Systems, Inc) test, a lateral-flow immunoassay to
identify the presence of M. bovis antibodies, and iii) microbiolog-
ical culture of clinical samples (i.e. sputum, faeces, urine and
wound/abscess swabs) to isolate M. bovis (see [25,26] for
discussion of the performance of each test). We used a simplified
version of the disease classification discussed in detail in [16].
Briefly, individuals were classed as ‘negative’ if they had never
tested positive for bTB on any test, ‘positive’ if they had ever tested
positive using the STAT-PAK or IFNc tests, or ‘excretor’ if M.
bovis was isolated by culture. Thirteen individuals transitioned to a
more advanced disease statuses during the course of the study:
eleven individuals transitioned from disease ‘negative’ to ‘positive’,
one individual from ‘positive’ to ‘excretor’ and one individual from
‘negative’ to ‘excretor’. None of the individuals in this study have
ever been vaccinated against bTB.
Seasonality-corrected body condition
In order to control for variation in body condition (which could
conceivably be correlated with age or disease status) in the
telomere length analysis [27], we calculated a metric for body
condition that accounted for the marked seasonal variation in
body mass exhibited by European badgers. To do so, we first
calculated the Scaled Mass Index (SMI) for all individuals at each
capture, following [28]. This approach factors out variation in
body mass arising from variation in body size (in this case utilising
body length (cm) as the metric of body size), by scaling the body
mass measure for each capture to that for an individual of average
size (in this case, of body length = 80 cm). The SMI scaling factor
was estimated to be 3.63. We then corrected all SMI measures for
seasonal variation by taking residuals from a model of SMI that
controlled for variation arising from the month of the year on
which the individual was captured.
Statistical analyses
Competing hypotheses for the causes of variation in telomere
length were compared using multi-model inference [29] with
linear mixed-models. A priori candidate models (n = 28) were
defined containing additive effects of all candidate explanatory
variables: partitioned age (see explanation below), sex, bTB status,
seasonally-corrected body condition and all biologically relevant
two way interactions (see Information S2 for full model selection
table). A ‘top model set’ was defined, which included all models
with DAICc#6 from the best supported model, after excluding
any models of which a simpler nested version attained stronger
support (following the ‘nesting rule’ of [30]). All co-efficients were
model-averaged across the models in the ‘top model set’ in which
they occurred using the MuMIn package [31]. Model-averaged
coefficients (effects sizes) are discussed in terms of their relative
‘weights’. In order to ensure that our statistical assessment of the
within-individual change in telomere length with age was not
confounded by between-individual effects (e.g. selective disappear-
ance), we applied a within-subject centring approach, following
Age-Related Changes in Immune Cell Telomere Length
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[32]. Age was partitioned into (i) an individual’s ‘mean age’ across
all samples collected for that individual, and (ii) its ‘D age’ (the
offset of its age at the focal sampling point from its mean age, the
effect of which reflects within-individual changes in telomere
length with age). Previous longitudinal and cross-sectional studies
of immune cell telomere lengths have suggested that the rate of
telomere attrition may slow with increasing age [33,34]. To
address this possibility, we assess the strength of evidence for
quadratic effects of each partitioned age parameter and for an
interaction between a mean age and D age. To account for
repeated measures, qPCR plate heterogeneity, and variation in
territory quality, we included ‘individual ID’ nested within ‘plate
ID’ (all samples from the same individual were run on the same
plate) and ‘social group’ as random intercept terms. Goodness-of-
fit was assessed through calculating conditional (total variance
explained by the best supported model) and marginal (variance
explained by fixed effects alone) R2 formulations [35] and
standard residual plot techniques.
Results
The relationship between age and immune cell telomere length,
after accounting for the effects of the random factors, is strongly
suggestive of the predicted age-related decline (Figure 1A).
Crucially, partitioning variance in age into within- and between-
individual variation yielded full statistical support for age-related
declines in telomere length occurring within individuals (Figure 1B
and Table 1). The rate of telomere attrition with age occurring
within individuals (mean6SE = 4606170 bp/year) was estimated
to be over three times faster than that for between-individual
increases in age (mean6SE = 140640 bp/year; Table 1). We
found no statistical support for quadratic age effects or an
interaction between mean age and D age, suggesting that the rate
of change in mean immune cell telomere length does not change
with age.
We also found some support for bTB infection status predicting
telomere length (Table 1), whereby bTB positive individuals had
longer telomere lengths than negative individuals, while individ-
uals in advanced stages of infection (‘excretors’) showed shorter
telomere lengths than badgers that tested positive (Figure 2). No
support was found for bTB infections status influencing the rate of
within-individual telomere attrition (an interaction between bTB
status and D age). Likewise, no support was found for sex or
current body condition influencing telomere length. The propor-
tion of variance explained by the best performing model was
59.7%, though the fixed effects alone (age and disease) accounted
for just 5.1% of the total variance.
Discussion
Our findings strongly suggest that the age-related declines in
immune cell telomere length observed in humans and laboratory
models are mirrored by comparable relationships in this popula-
tion of wild mammals. These results therefore lend strength to the
suggestion that age-related declines in immune cell telomere
length may contribute to the emergence of the immunosenescent
phenotypes increasingly documented in wild vertebrate popula-
tions [9]. Our findings are also suggestive of associations between
immune cell telomere lengths and disease status in the wild,
echoing the findings of biomedical research in which human
immune cell telomere lengths have been identified as a risk factor
for disease [5]. Below we discuss the causal mechanisms that may
underpin the relationships observed and their implications, in light
of existing work on the telomere dynamics of other cell types in
wild vertebrates, for our understanding of patterns of senescence in
the wild.
Our findings suggest that the immune cell populations of wild
European badgers experience a decline in mean telomere length of
approximately 460 bp/year with increasing organismal age. This
rate of decline falls between recent estimates for the immune cell
telomere attrition rates of humans (72 bp/year) and laboratory
Figure 1. How telomere length changes with age and partitioned age. (A) Relationship between immune cell telomere length (TL) and age
(years) whilst controlling for random effects; (B) and (C) Relationship between TL and D age (within-individual changes in age) and TL and mean age
(between-individual changes in age) respectively while controlling for random effects, bTB infection status, and between-individual differences in age
(Table 1); Black lines present model averaged predictions, shaded areas present 95% confidence intervals, and black points present residuals from the
best supported models.
doi:10.1371/journal.pone.0108964.g001
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mice (7000 bp/year) [2] and is consistent with the previously
documented negative correlation between telomere attrition rate
and lifespan [4]. The observed age-related declines in mean
immune cell telomere length could principally reflect age-related
changes in the telomere lengths of particular immune cell classes,
the immunological implications of which will depend upon the cell
class(es) involved. For example, the observed patterns may
principally reflect age-related declines in the telomere lengths of
neutrophils as they typically comprise around 80% of total
immune cell counts in the European badger [36,37]. As the high
turnover rate of neutrophils is thought to leave their telomere
lengths reflecting those of the haematopoietic stem cells from
which they derive [12,38], it seems likely that our results reflect, at
least in part, age-related declines in haematopoietic stem cell
telomere length. To the extent that this is the case, our findings
echo those of studies of wild birds, in which the telomere lengths of
nucleated erythrocytes (which also derive from the haematopoietic
stem cells) have typically been found to decrease with age [4,7,8].
Collectively these findings highlight the possibility that patholog-
ical consequences of short telomeres in this stem cell compartment
[11,39] may contribute to age-related declines in whole-organism
performance. However, as lymphocytes also represent a significant
proportion of European badger immune cells (,20%; [36,37]),
our findings may also reflect, at least in part, age-related declines
in lymphocyte telomere lengths, whose dynamics may differ
markedly from those of the haematopoietic stem cells. Age-related
declines in the telomere lengths of lymphocytes per se have
previously been documented in humans and laboratory models
[33,40], and, given the potential for short telomeres to limit
lymphocyte proliferation capacity [13], have been implicated as
one potential driver of late-life declines in the capability of the
adaptive immune system. The application of cell sorting to field-
derived samples of immune cell populations prior to telomere
analysis might now be usefully prioritised, to clarify which immune
cell sub-types are exhibiting age-related declines in telomere length
and, by extension, the immunological implications of such
declines.
While our findings could indeed reflect age-related declines in
the telomere lengths of specific immune cell subsets that might
thereby contribute to the emergence of immunosenescent pheno-
types, there are several reasons for caution when considering this
possibility. First, it is also possible that the observed age-related
changes in immune cell mean telomere length instead arise in part
from changes with age in the ratios of immune cell sub-types in
circulation [41], which may differ in mean telomere length (e.g. an
increasing representation of memory T-cells with shorter telo-
meres relative to naı¨ve T-cells with longer telomeres) [6].
Ultimately, the relative contributions of telomere attrition per se
versus age-related changes in immune cell composition will only
become clear once cell-type-specific telomere length estimates can
be coupled with knowledge of age-related changes in the ratios of
these same cell types, which is currently an ambitious prospect for
studies of non-model organisms. Second, even if the observed age-
related changes do arise from within-cell-type changes in telomere
length, our statistical models highlight that the fixed effects alone
(age and disease status) explain only a small proportion of the
observed variation in mean immune cell telomere length (just 5%),
Table 1. Model averaged output of linear mixed model analysis of the factors affecting telomere length: S=model weight,
SE = effect size standard error, CI = confidence interval, a = factor levels.
Parameter S Effect size SE 95% CI
Mean Age (Years) 1.0 20.14 0.04 (20.22 to 20.05)
Delta Age (Years) 1.0 20.46 0.17 (20.80 to 20.12)
Disease 0.7 2 - -
- aNegative 0.00 - -
- aPositive 0.24 0.23 (20.03 to 0.74)
- aExcretor 20.26 0.37 (21.13 to 0.40)
Sex 0.0 - - -
Condition 0.0 - - -
Interaction terms without support are not shown. For full model output see Information S2.
doi:10.1371/journal.pone.0108964.t001
Figure 2. Predicted change in TL due to bTB infection status.
Where the dashed line is the predicted TL of bTB negative individuals, ‘+
ve’ denotes disease positive individuals, and ‘ex’ individuals classed as
excretors. The points present model averaged predictions and error
bars present their 95% confidence intervals.
doi:10.1371/journal.pone.0108964.g002
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suggesting that the biological significance of these within-
individual changes with age may be limited relative, for example,
to the processes that generate between-individual variation.
Finally, while the observed age-related declines in mean telomere
length could be a pathological consequence of cumulative
exposure to the diverse processes that may shorten immune cell
telomere lengths (e.g. oxidative stress or disease), it is also possible
that they reflect, in part or whole, adaptive changes in
immunological investment with age (either in telomere mainte-
nance or immune cell sub-type ratios), given, for example, a
reduced likelihood that older individuals will encounter novel
pathogens. Whether naturally occurring age-related changes in
immune cell telomere length necessarily would contribute to late-
life declines in whole organism performance in natural populations
under ecologically realistic conditions therefore remains open to
debate.
Our findings are also suggestive of an association between
disease state and immune cell telomere length in a natural
vertebrate population under ecologically realistic conditions, again
echoing studies of humans and laboratory models [14] However, it
must be noted that due to the low frequency of indviduals
transitiong between disease states within the study period these
patterns are largely cross-sectional in nature. The initial increase in
telomere length with the transition to testing positive for bTB was
unexpected; however, previous work in humans found telomerase
activity to be present in immune cells of individuals with
pulmonary tuberculosis and absent in healthy controls [42]. As
the immune responses to bTB comprise of both cell-mediated and
humoral components [43], involving T and B-cells which are
known to express telomerase [6,44], telomerase expression in
immune cell subsets during infection may be contributing to this
pattern. The apparent decrease in immune cell telomere length
associated with progression from testing positive for bTB to
excreting the bacterium is consistent with evidence that disease
progression in humans is linked to the shortening of immune cell
telomeres [3]. Whether this association reflects short telomeres
pre-disposing individuals to disease progression [6], the impacts of
infection on immune cell telomere length [14], or indeed a role for
other processes that may both shorten immune cell telomeres and
leave individuals pre-disposed to disease progression, remains
unclear. It is also conceivable that these patterns reflect disease-
associated variation in the composition of the immune cell
population from which our telomere length assessments derive,
rather than variation in the telomere lengths of specific cell types.
As the presence of critically short telomeres (rather than an overall
decline in population average telomere length) may act as the
crucial factor linking disease progression and immune cell viability
[45,46], this possible link between disease status and telomere
dynamics may be more appropriately addressed using methodol-
ogies with single chromosome resolution [see 20].
Our findings have implications too for a growing body of work
seeking to understand the causes and consequences of sex
differences in telomere dynamics [47]. It has been argued, for
example, that males might be expected to show shorter telomeres
and/or experience higher rates of telomere attrition in species that
exhibit male-biased sexual size dimorphism, male-biased mortality
rates and/or steeper rates of senescence decline among males than
females (reviewed in [47]). As all three phenomena have been
documented in the European badger [15,48,49], it is notable that
our findings reveal no evidence of a sex difference in either mean
immune cell telomere length or in the within-individual rate of
immune cell telomere attrition with age. Our findings therefore
echo recent work highlighting the likely complexity of the
proximate and ultimate causes of sex differences in telomere
dynamics, and the difficulty of drawing generalisations from the
small number of studies in this area to date [47].
In summary, our findings provide the first evidence, to our
knowledge, of within-individual declines in immune cell telomere
length with age in a wild vertebrate, suggesting that the immune
cell telomere attrition documented in humans and laboratory
models may indeed generalise to natural vertebrate populations
experiencing ecologically realistic conditions. As such, while their
immunological implications will only become clear with further
research, our findings do lend strength to the view that age-related
declines in immune cell telomere length may offer one potentially
general mechanism contributing to declines in both immune and
whole-organism performance with age. It remains to be tested
whether short immune cell telomeres are associated with weaker
whole-organism performance in the wild as appears to be the case
for erythrocyte telomere length in wild birds [7,50,51]. However,
that our statistical models estimate the rate of within-individual
age-related decline in immune cell telomere length to be roughly
three times faster than the rate of between-individual decline is at
least consistent with a scenario where individuals with shorter
immune cell telomeres and/or faster telomere attrition rates are
selectively disappearing from this population. A key challenge now
will be establishing the causes of variation among individuals in the
rate of immune cell telomere attrition with age, and the extent to
which such variation has causal effects on late-life health and
performance.
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